Hollow fibers are highly valued in the textile industry. Their physical properties and other superior characteristics make them a crucial material for innovations in textiles in the medical field, where they could provide solutions to therapeutic challenges. The inner lumen of hollow fibers has potential for use in medical and healthcare devices. For example, hollow fibers could be used to deliver drugs to a target site, enhance blood purification, promote cell cultures, and enable drug screening. The use of hollow fibers could have beneficial effects for medical and therapeutic performance; a market for hollow fiber-based medical clothing is anticipated for promotion of an efficient, long-term, and convenient commercial medical therapy. This review discusses the development of medical textiles and describes the use of hollow fibers in different medical contexts, as well as the benefits of their use and their potential industrial applications in medical textiles and clothing.
EdwardsJVFuture structure and properties of mechanism-based wound dressings. In: EdwardsJVBuschle-DillerGGoheenSC (eds). Modified fibers with medical and specialty applications, Dordrecht: Springer Verlag, 2006, pp. 12–12.
2.
BideMPhaneufMBrownPet al.Modification of polyester for medical uses. In: EdwardsJVBuschle-DillerGGoheenSC (eds). Modified fibers with medical and specialty applications, Dordrecht: Springer Verlag, 2006, pp. 91–124.
3.
SinghCWongCSWangX. Medical textiles as vascular implants and their success to mimic natural arteries. J Funct Biomater2015; 6: 500–525. DOI: 10.3390/jfb6030500.
4.
Warner SM. Biomedical textiles: a fast-growing market. Textile World 2014; 20.
5.
SrinivasuluKKumarDN. A review on properties of surgical sutures and applications in medical field. Int J Res Eng Technol2014; 2: 85–96.
RajendranSInfection control and barrier materials: an overview. In: AnandSCKennedyJFMiraftabMet al.(eds). Medical and healthcare textiles, Cambridge: Woodhead Publishing Limited, 2010, pp. 3–6.
8.
KennedyJFKnillCJTextile-based medical devices: an overview. In: AnandSCKennedyJFMiraftabMet al.(eds). Medical and healthcare textiles., Cambridge: Woodhead Publishing Limited, 2010, pp. 391–395.
9.
BideMJPhaneufMDPhaneufTMControlled drug release from nanofibrous polyester materials. In: AnandSCKennedyJFMiraftabMet al.(eds). Medical and healthcare textiles, Cambridge: Woodhead Publishing Limited, 2010, pp. 198–205.
10.
MuhammadFKTanveerHRashidMet al.Development and evaluation of a controlled drug delivery wound dressing based on polymeric porous microspheres. J Ind Textiles2015; 46(3): 986–999.
11.
OltargevskayaNDKrichevskyGETextile finishing for the production of new generation medical textiles. In: AnandSCKennedyJFMiraftabMet al.(eds). Medical textiles and biomaterials for healthcare, Cambridge: Woodhead Publishing Limited, 2006, pp. 482–490.
12.
LazzeriLCasconeMGQuiriconiSet al.Biodegradable hollow microfibres to produce bioactive scaffolds. Polym Int2005; 54: 101–107. DOI: 10.1002/pi.1648.
13.
ElahiMFWangLGuanGet al.Core–shell fibers for biomedical applications: a review. J Bioeng Biomed Sci2013, pp. 3–3. DOI: 10.4172/2155-9538.1000121.
14.
BettahalliNMSVicenteJMoroniLet al.Integration of hollow fiber membranes improves nutrient supply in three-dimensional tissue constructs. Acta biomaterialia2011; 7: 3312–3324. DOI: 10.1016/j.actbio.2011.06.012.
15.
MochI. Hollow-fiber membranes. In: Desalination and water resources membrane processes2010; Vol. 1, Oxford: EOLSS, pp. 284–317.
16.
GetuASahuO. Technical fabric as health care material. Biomedical Science and Engineering2014; 2: 35–39.
17.
RafatMDeDKhulbeKCet al.Surface characterization of hollow fiber membranes used in artificial kidney. J Appl Polym Sci, 101, 2006, pp. 4386–4400. DOI: 10.1002/app.23052.
18.
RoncoCCrepaldiCBrendolanAet al.Evolution of synthetic membranes for blood purification: the case of the polyflux family. Nephrol Dial Transplant2003; 18: vii10–vii20.
19.
CadwellJJS. The hollow fiber infection model for antimicrobia pharmacodynamics and pharmacokinetics. Adv Pharmacoepidemiol Drug Saf2012; S1: 007–007. DOI: 10.4172/2167-1052.S1-007.
Cadewell JSS. New developments in hollow-fiber cell culture. Am Biotechnol Lab 2004; 14.
23.
WilliamsDPShipleyREllisMJet al.Novel in vitro and mathematical models for the prediction of chemical toxicity. Toxicol Res2013; 2: 40–59. DOI: 10.1039/C2TX20031G.
SuggittMSwaineDJPettitGRet al.Characterization of the hollow fiber assay for the determination of microtubule disruption in vivo. Clin Cancer Res2004; 10: 6677–6685. DOI: 10.1158/1078-0432.CCR-04-0855.
26.
PhillipsRMPearceJLoadmanPMet al.Angiogenesis in the hollow fiber tumor model influences drug delivery to tumor cells: implications for anticancer drug screening programs. Cancer Res1998; 58: 5263–5266.
27.
ZhangGJChenTBBednarBet al.Optical imaging of tumor cells in hollow fibers: evaluation of the antitumor activities of anticancer drugs and target validation. Neoplasia2007; 9: 652–661. DOI: 10.1593/neo.07421.
28.
UludagHDe VosPTrescoPA. Technology of mammalian cell encapsulation. Adv Drug Deliv Rev2000; 42: 29–64. DOI: 10.1016/S0169-409X(00)00053-3.
29.
Chen X. . Production of nylon 6 filaments with the research and development exchange on the new trends of fiber technology. Guangdong: XinHui Media Nylon Co. Ltd, 2014.
30.
WalzMOccupational clothing for nurses: combining improved comfort with economic efficiency. In: BartelsT (ed). Handbook of medical textiles, Cambridge: Woodhead Publishing Limited, 2011, pp. 461–480.
31.
MartíMLisMNavarroJet al.Smart textiles with slow-release ceramides for sensitive skin. In: AnandSCKennedyJFMiraftabMet al.(eds). Medical and healthcare textiles, Cambridge: Woodhead Publishing Limited, 2010, pp. 509–516.
32.
Wollina U, Abdel-Naser MB and Verma S. Skin physiology and textiles: consideration of basic interactions. In: Hipler U-C and Elsner P (eds.) Biofunctional textiles and the skin. Basel: Karger, 2006, ch. 1.
33.
NockerWEvaluation of occupational clothing for surgeons achieving comfort and avoiding physiological stress through suitable gowns. In: BartelsT (ed). Handbook of medical textiles, Cambridge: Woodhead Publishing Limited, 2011, pp. 443–459.
34.
Banse T. New-Frontier fabrics. Popular Mechanics 1990; March: 92.
35.
JiangSXuYZhangHet al.Seven-hole hollow polyester fibers as reinforcement in sound absorption chlorinated polyethylene composites. Appl Acoustics2012; 73: 243–247. DOI: 10.1016/j.apacoust.2011.09.006.
36.
LoebS. Reverse osmosis: introduction. Desalination and water resources membrane processes2010; Vol. 1, Oxford: EOLSS, pp. 269–283.
BakerRWMembrane technology. In: MarHF (ed). Encyclopedia of polymer science and technology, concise, Hoboken, NJ: John Wiley & Sons, 2007, pp. 658–668.
39.
VandekarVD. Manufacturing of hollow fiber membrane. Int J Sci Res2013; 4: 1990–1993.
40.
Puri PS. Spinneret for making hollow fibers having different wall thicknesses. European Patent EP 0277619 A2, Munich, Germany, 1988 (accessed date 18 Feb 2016).
LiS-GKoopsGHMulderMHVet al.Wet spinning of integrally skinned hollow fiber membranes by a modified dual-bath coagulation method using a triple orifice spinneret. J Membr Sci1994; 94: 329–340. DOI: 10.1016/0376-7388(94)00076-X.
44.
KimJHwangJRKimUYet al.Operation parameters of melt spinning of polypropylene hollow fiber membranes. J Membr Sci1995; 108: 25–36. DOI: 10.1016/0376-7388(95)00148-7.
45.
WienkIMOlde ScholtenhuisFHAvan den BoomgaardTet al.Spinning of hollow fiber ultrafiltration membranes from a polymer blend. J Membr Sci1995; 106: 233–243. DOI: 10.1016/0376-7388(95)00088-T.
46.
WangDLiKTeoWK. Preparation and characterization of polyvinylidene fluoride (PVDF) hollow fiber membranes. J Membr Sci1999; 163: 211–220. DOI: 10.1016/S0376-7388(99)00181-7.
47.
SchakenraadJMOosterbaanJANieuwenhuisPet al.Biodegradable hollow fibres for the controlled release of drugs. Biomaterials1988; 9: 116–120. DOI: 10.1016/0142-9612(88)90082-8.
48.
van de WittePEsselbruggeHPetersAMPet al.Formation of porous membranes for drug delivery systems. J Control Release1993; 24: 61–78. DOI: 10.1016/0168-3659(93)90168-5.
49.
ArahmanNArifinBMulyatiSet al.Structure change of polyethersulfone hollow fiber membrane modified with Pluronic F127, polyvinylpyrrolidone, and Tetronic 1307. Mater Sci Appl2012; 3: 72–77. DOI: 10.4236/msa.2012.32011.
50.
Lin K and Chang J. Preparation and mechanism of novel bioceramics with controllable morphology and crystal growth. In: Wu C, Chang J, and Xiao Y (eds.) Advanced bioactive inorganic materials for bone regeneration and drug delivery. Boca Raton, FL: CRC Press, 2013, pp.147–169.
51.
Xia Y and Li D. Electrospinning of fine hollow fibers. US Patent US7575707 B2. United States, 2009.
52.
Li F, Zhao Y, and Song Y. Core–shell nanofibers: nano channel and capsule by coaxial electrospinning. In: Kumar A (ed.) Nanofibers. n.p: InTech, 2010, ch. 22.
53.
HonguTPhillipsGOTakigamiM. New millennium fibers, Cambridge: Woodhead Publishing Limited, 2005, pp. 189–194.
Max H. Textiles. In: Siegel J. (ed) Forensic chemistry: fundamentals and applications. Oxford: John Wiley & Sons, Ltd, 2015, pp. 55.
58.
SongGThermal insulation properties of textiles and clothing. In: WilliamsJT (ed). Textiles for cold weather apparel, Cambridge: Woodhead Publishing Limited, 2009, pp. 25–25.
59.
KhoddamiACarrCMGongRH. Effect of hollow polyester fibres on mechanical properties of knitted wool/polyester fabrics. Fibers Polym2009; 10: 452–460. DOI: 10.1007/s12221-009-0452-7.
60.
SongGMandalSTesting and evaluating the thermal comfort of clothing ensembles. In: WangL (ed). Performance testing of textiles: methods, technology and applications, Cambridge: Woodhead Publishing Limited, 2016, pp. 42–42.
61.
Suzuki T. Overview of functional and speciality fibers. In: The Society of Fiber Science and Technology, Japan (ed.) High-performance and specialty fibers: concepts, technology and modern applications of man-made fibers for the future. Tokyo: Springer, 2016, p.230.
GorriDUrtiagaAOrtizISupported liquid membranes for pervaporation processes. In: DrioliEGiornoL (eds). Comprehensive membrane science and engineering volume I: basic aspects of membrane science and engineering, Kidlington: Elsevier, 2010, pp. 326–345.
64.
Zielinski JM and Kettle L. Physical characterization: surface area and porosity. Intertek Chemicals and Pharmaceuticals, www.intertek.com/chemicals (2013) (accessed date 11 Mar 2016).
65.
YangL. Nanotechnology-enhanced orthopedic materials: fabrications, applications and future trends, Cambridge: Woodhead Publishing Limited, 2015, pp. 143–143.
66.
GulgunjePVNewcombBAGuptaKet al.Low-density and high-modulus carbon fibers from polyacrylonitrile with honeycomb structure. Carbon2015; 95: 710–714. DOI: 10.1016/j.carbon.2015.08.097.
67.
TiwariGTiwariRSriwastawaBet al.Drug delivery systems: an updated review. Int J Pharm Invest2012; 2: 2–11. DOI: 10.4103/2230-973X.96920.
68.
NatuMVde SousaHCGilMH. Effects of drug solubility, state and loading on controlled release in bicomponent electrospun fibers. Int J Pharm2013; 397: 50–58.
69.
TozerTNRowlandM. Introduction to pharmacokinetics and pharmacodynamics: the quantitative basis of drug therapy, Philadelphia, PA: Lippincott Williams & Wilkins, 2006.
DiPiroJTSpruillWJWadeWEet al.Concepts in clinical pharmacokinetics, Bethesda, MD: American Society of Health-System Pharmacists, 2010.
72.
KimKKPackDWMicrospheres for drug delivery. In: FerrariMLeeAPLeeLJ (eds). BioMEMS and biomedical nanotechnology volume I: biological and biomedical nanotechnology, New York: Springer Verlag, 2006, pp. 19–50.
73.
SiegelRARathboneMJOverview of controlled release mechanisms. In: SiepmannJSiegelRARathboneMJ (eds). Fundamentals and applications of controlled release drug delivery, advances in delivery science and technology, New York: Springer Verlag, 2012.
74.
ZengLAnLWuX. Modeling drug–carrier interaction in the drug release from nanocarriers. J Drug Deliv2011; 2011: 370308–370308. DOI: 10.1155/2011/370308.
75.
YanXMariniJMulliganRet al.Slit-surface electrospinning: a novel process developed for high-throughput fabrication of core–sheath fibers. PLoS One2015; 10: e0125407–e0125407. DOI: 10.1371/journal.pone.0125407.
76.
Sirkar KK, Farrell S, and Basu R. Controlled release device and method based on aqueous–organic partitioning in porous membranes. US Patent US 5858385 A. United States, 1999.
77.
SolaroRChielliniFBattistiA. Targeted delivery of protein drugs by nanocarriers. Materials2010; 3: 1928–1980. DOI: 10.3390/ma3031928.
78.
ten BretelerMRNierstraszVAWarmoeskerkenMMCG. Textile slow-release systems with medical application. Autex Res J2002; 2: 175–189.
79.
CabanSAytekinESahinACapanY. Nanosystems. OA Drug Design & Delivery201418; 2(1): 2.
80.
AshjaranANamayiA. Survey on nanofiber material as drug delivery systems. Res J Pharm Biol Chem Sci2014; 5: 1262–1274.
81.
Ahn SS. Drug delivery system using hollow fibers. European Patent EP 0684815 A4, Germany, 1997.
82.
LangerR. Invited review polymeric delivery systems for controlled drug release. Chem Eng Commun1980; 6: 1–48. DOI: 10.1080/00986448008912519.
83.
HoeferDHohnG. A novel in situ self-dissolving needle web based on medicated cellulose hollow fibres with drug delivery features. Open Med Devices J2011; 3: 1–8. DOI: 10.2174/1875181401103010001.
KulierRO’BrienPHelmerhorstFMet al.Copper containing, framed intra-uterine devices for contraception, Geneva: John Wiley & Sons, 2008, pp. 2–3.
86.
OstadSNGardPR. Cytotoxicity and teratogenicity of chlorhexidine diacetate released from hollow nylon fibres. J Pharm Pharmacol2000; 52: 779–784. DOI: 10.1211/0022357001774633.
87.
GardPRReynoldsJPHanlonGW. Use of chlorhexidine-releasing nylon fibres to reduce device-related uterine infections. Gynecol Obstet Invest2000; 49: 261–265. DOI: 10256.
88.
OstadSNMalhiJSGardPR. In vitro cytotoxicity and teratogenicity of norethisterone and levonorgestrel released from hollow nylon monofilaments. J Control Release1998; 50: 179–186.
89.
EeninkMJDFeijenJOlijslagerJet al.Biodegradable hollow fibres for the controlled release of hormones. J Control Release1987; 6: 225–247. DOI: 10.1016/0168-3659(87)90079-4.
90.
PanwarMGuptaSH. Local drug delivery with tetracycline fiber: an alternative to surgical periodontal therapy. Med J Armed Forces India2009; 65: 244–246. DOI: 10.1016/S0377-1237(09)80014-2.
91.
OhSOdlandRWilsonSRet al.Improved distribution of small molecules and viral vectors in the murine brain using a hollow fiber catheter. J Neurosurg2007; 107: 568–577. DOI: 10.3171/JNS-07/09/0568.
92.
AnandVKandarapuRGargS. Ion-exchange resins: carrying drug delivery forward. Drug Discov Today2001; 6: 905–914. DOI: 10.1016/S1359-6446(01)01922-5.
93.
AkelahA. Functionalized polymeric materials in agriculture and the food industry, New York: Springer Verlag Science + Business Media, 2013.
94.
HongYChenXJingXet al.Fabrication and drug delivery of ultrathin mesoporous bioactive glass hollow fibers. Adv Funct Mater2010; 20: 1503–1510. DOI: 10.1002/adfm.200901627.
95.
KraitzerAOfekLSchreiberRet al.Long-term in vitro study of paclitaxel-eluting bioresorbable core/shell fiber structures. J Control Release2008; 126: 139–148. DOI: 10.1016/j.jconrel.2007.11.011.
96.
LiGLiYChenGet al.Silk-based biomaterials in biomedical textiles and fiber-based implants. Adv Healthc Mat2015; 4: 1134–1151. DOI: 10.1002/adhm.201500002.
97.
AkterSAzimAYMAAl FaruqueMA. Medical textiles: significance and future prospect in Bangladesh. Eur Sci J2014; 10: 1857–7881.
98.
MacLarenGCombesABartlettRH. Contemporary extracorporeal membrane oxygenation for adult respiratory failure: life support in the new era. Intensive Care Med2012; 38: 210–220. DOI: 10.1007/s00134-011-2439-2.
99.
EashHJJonesHMHattlerBGet al.Evaluation of plasma resistant hollow fiber membranes for artificial lungs. ASAIO J2004; 50: 491–497.
NickersonBColónILiquid–liquid and solid-phase extraction techniques. In: NickersonB (ed). Sample preparation of pharmaceutical dosage forms: challenges and strategies for sample preparation and extraction, New York: Springer Verlag, 2011, pp. 63–92.
. Production of nylon 6 filaments with the research and development exchange on the new trends of fiber technology. Guangdong: XinHui Media Nylon Co. Ltd, 2014